TheFly reported on April 7 that Citigroup lowered its rating on BIO from Buy to Neutral and reduced its price target from ...

While we can mathematically quantify the corresponding risk to laboratory workers, extending that risk assessment to the local and global community poses numerous challenges. First, we need a full ...

From cell biology to ecosystems, virtual labs are making science more interactive, accessible, and engaging than ever. Students can experiment, make mistakes, and learn in safe, flexible environments.

The process of discovering a new drug has historically been agonisingly slow and tremendously expensive. In recent years, artificial intelligence has promised to drastically accelerate this timeline ...

OpenAI has released GPT-Rosalind, a large language model fine-tuned specifically for life sciences research, marking the company’s most direct push yet into computational biology and drug discovery.